Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clusterin (CLU), also known as Apolipoprotein J, is a multifunctional, secreted glycoprotein that acts primarily as an extracellular molecular chaperone. It is widely expressed and found in various body fluids. Clusterin binds misfolded proteins, inhibits apoptosis, and prevents complement-mediated cell lysis. Alterations in clusterin expression are implicated in numerous diseases, including Alzheimer's disease and cancer.
Acts as an ATP-independent molecular chaperone for misfolded proteins; inhibits apoptosis by interacting with BAX on mitochondria and modulating survival pathways; prevents complement-mediated cell lysis by binding terminal complement complexes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clusterin (CLU).